Vox Markets Logo

Specialist Intellectual Property Firm Acquires Antibiotics Company

12:09, 24th September 2018
Abraham Darwyne
Company News
TwitterFacebookLinkedIn

Frontier IP (FIPP) FOLLOW announced on Thursday it has acquired a 10% stake in Amprologix Limited, a spin-out from the University of Plymouth. The company has been established to introduce new antibiotics to tackle antimicrobial resistance, a major threat to human health globally.

First product cream containing epidermicin – combat infections caused by antibiotic resistant bacteria. It rapidly kills harmful bacteria even if they are resistant to other antibiotics and even at very low doses.

No new classes of antibiotics have been introduced into clinical use for the past 30 years. The company aims to meet growing need for new antibiotics as microbes become increasingly drug resistant

Working with IBM, the National Physical Laboratory and Ingenza, the company focus is using Artificial Intelligence to improve antibiotic properties. The partnership with biotechnology and synthetic biology company Ingenza will allow the company to manufacture antibiotics at scale.

The World Health Organisation warned in February this year that "antibiotic resistance is one of the biggest threats to global health, food security, and development today".

Frontier IP (FIPP) was up over 10p per share by the end of the week following the announcement.

Follow news & updates about Frontier IP (FIPP) here: FOLLOW

 

TwitterFacebookLinkedIn

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Recent Articles
Watchlist